Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 0.934 Q2 | 202 | 382 | 1048 | 47291 | 4223 | 959 | 3.80 | 123.80 | 47.17 | |
2 | Current Pharmaceutical Design | journal | 0.690 Q2 | 183 | 515 | 1637 | 53255 | 5006 | 1517 | 2.78 | 103.41 | 43.76 | |
3 | Current Drug Targets | journal | 0.826 Q2 | 119 | 141 | 450 | 15650 | 1540 | 422 | 3.15 | 110.99 | 40.00 | |
4 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.508 Q3 | 108 | 231 | 590 | 14800 | 1433 | 572 | 2.31 | 64.07 | 41.05 | |
5 | Mini-Reviews in Medicinal Chemistry | journal | 0.603 Q3 | 107 | 149 | 359 | 14217 | 1277 | 339 | 3.65 | 95.42 | 42.91 | |
6 | Current Cancer Drug Targets | journal | 0.972 Q2 | 103 | 75 | 237 | 5949 | 734 | 219 | 3.13 | 79.32 | 38.95 | |
7 | Current Neuropharmacology | journal | 1.955 Q1 | 103 | 78 | 283 | 11625 | 2008 | 257 | 6.61 | 149.04 | 44.61 | |
8 | CNS and Neurological Disorders - Drug Targets | journal | 0.923 Q2 | 96 | 65 | 287 | 5920 | 1076 | 265 | 3.94 | 91.08 | 39.63 | |
9 | Current Vascular Pharmacology | journal | 0.806 Q2 | 69 | 76 | 225 | 5973 | 643 | 197 | 2.27 | 78.59 | 30.77 | |
10 | Infectious Disorders - Drug Targets | journal | 0.322 Q3 | 61 | 122 | 116 | 4449 | 166 | 112 | 1.47 | 36.47 | 44.14 | |
11 | Current Molecular Pharmacology | journal | 0.717 Q2 | 49 | 32 | 89 | 2336 | 258 | 81 | 3.21 | 73.00 | 44.76 | |
12 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.365 Q3 | 45 | 41 | 86 | 1604 | 141 | 81 | 1.64 | 39.12 | 36.49 | |
13 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.415 Q3 | 43 | 17 | 49 | 759 | 95 | 43 | 1.88 | 44.65 | 32.14 | |
14 | Current Drug Safety | journal | 0.334 Q3 | 41 | 36 | 117 | 1064 | 177 | 114 | 1.79 | 29.56 | 40.52 | |
15 | Reviews on Recent Clinical Trials | journal | 0.509 Q3 | 35 | 44 | 130 | 1929 | 200 | 115 | 1.47 | 43.84 | 32.78 | |
16 | Current Radiopharmaceuticals | journal | 0.586 Q3 | 32 | 23 | 92 | 922 | 228 | 84 | 3.09 | 40.09 | 37.50 | |
17 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.296 Q3 | 27 | 34 | 39 | 1670 | 67 | 36 | 1.63 | 49.12 | 47.78 | |
18 | Anti-Infective Agents | journal | 0.178 Q4 | 26 | 47 | 55 | 1753 | 37 | 51 | 0.76 | 37.30 | 38.06 | |
19 | Open Medicinal Chemistry Journal | journal | 0.294 Q3 | 23 | 12 | 33 | 758 | 63 | 31 | 1.61 | 63.17 | 48.08 | |
20 | Current Pharmacogenomics and Personalized Medicine | journal | 0.264 Q3 | 20 | 24 | 37 | 969 | 35 | 33 | 1.24 | 40.38 | 48.57 | |
21 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.157 Q4 | 17 | 0 | 25 | 0 | 16 | 23 | 1.10 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®